Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHB3 | P54753 | 1/20 | 0.43 |
| ▸ | IGF1R | P08069 | 2/20 | 0.42 |
| ▸ | MCHR1 | Q99705 | 10/20 | 0.41 |
| ▸ | TNK2 | Q07912 | 2/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.40 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | HRH1 | P35367 | 1/20 | 0.40 |
| ▸ | HTR7 | P34969 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29548844 | 1.00 | EPHB3 (0.43) | EPHB3IGF1RMCHR1TNK2KCNH2 | |
| SCHEMBL29548130 | 0.89 | EPHB3 (0.46) | EPHB3IGF1RMCHR1KCNH2HRH3 | |
| SCHEMBL29548553 | 0.86 | EPHB3 (0.48) | EPHB3IGF1RMCHR1TNK2KCNH2 | |
| SCHEMBL29548860 | 0.85 | EPHB3 (0.44) | EPHB3MCHR1KCNH2HRH3CYP2D6 | |
| SCHEMBL29548529 | 0.84 | EPHB3 (0.42) | EPHB3MCHR1KCNH2HRH3 | |
| SCHEMBL29548803 | 0.82 | EPHB3 (0.41) | EPHB3IGF1RMCHR1HRH3CYP2D6 | |
| SCHEMBL29548264 | 0.81 | EPHB3 (0.45) | EPHB3MCHR1KCNH2HRH3CYP2D6 | |
| SCHEMBL29548184 | 0.81 | EPHB3 (0.47) | EPHB3MCHR1KCNH2HRH3CYP2D6 | |
| SCHEMBL29548380 | 0.81 | EPHB3 (0.47) | EPHB3MCHR1KCNH2HRH3CYP2D6 | |
| SCHEMBL29548854 | 0.81 | EPHB3 (0.48) | EPHB3MCHR1KCNH2HRH3CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022070288-A1 | NITROGEN-CONTAINING BICYCLIC COMPOUND | 旭化成ファーマ株式会社 | 2022-04-07 | — | — | WO | disclosed |